Last reviewed · How we verify
Epidural lidocaine
At a glance
| Generic name | Epidural lidocaine |
|---|---|
| Also known as | epidural xylocaine |
| Sponsor | Hadassah Medical Organization |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Continous Infusion of Nefopam for Patients Undergoing Pancreatoduodenectomy (PHASE4)
- General Anesthesia and General Anesthesia Combined With Thoracic Epidural Anesthesia (NA)
- Thoracic Epidural Analgesia With Bilateral Erector Spinae Plane Block in Radical Cystectomy Surgery (NA)
- PAravertebral CaTheter Versus Epidural Analgesia in Totally Minimally Invasive Esophagectomies (NA)
- Efficacy of Sphenopalatine Block Compared to Blood Patch in the Management of Post-dural Puncture Headaches (PHASE3)
- SKIN WHEAL - Subcutaneous or Intradermal Lidocaine in Epidural for Laboring Pain. (NA)
- The Effect of Adding a Local Anesthetic to Transforaminal Epidural Injection in Cervical Disc Herniation. (NA)
- Spinal Anesthesia For Enhanced Recovery After Liver Surgery (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Epidural lidocaine CI brief — competitive landscape report
- Epidural lidocaine updates RSS · CI watch RSS
- Hadassah Medical Organization portfolio CI